NASDAQ
AbCellera Biologics Inc. (ABCL) has a current ratio of 11.32x as of Monday, May 25, 2026. This represents a 35.19% increase compared to its 12-month average of 8.38x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.